AstraZeneca (LSE:AZN): Is the Market Missing Its Next Growth Story?

AstraZeneca (LSE:AZN): Is the Market Missing Its Next Growth Story? →

Highlights TEZSPIRE delivers encouraging late-stage trial results. AstraZeneca's pipeline remains focused on major disease areas. Valuation remains a key point of investor attention. AstraZeneca's latest TEZSPIRE trial update adds fresh mom…